A Blood Test Could Detect Early Alzheimer's. That Could Make These 2 Stocks Red-Hot Buys.
Biogen (BIIB) Q2 2024 Earnings Call Transcript
Biogen (BIIB) Q2 2024 Earnings: Key financials and quarterly highlights
Why Biogen Stock Leaped Nearly 5% Higher Today
Biogen (BIIB) Q1 2024 Earnings Call Transcript
BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues
Biogen (BIIB) Q4 2023 Earnings Call Transcript
BIIB Earnings: Here’s everything you need to know about Biogen’s Q4 report
2 Popular Stocks to Avoid Like the Plague in 2024 and Beyond
The Alzheimer's Drug Market Is Heating Up. Should You Buy the Leading Contenders' Stocks?
Biogen (BIIB) Q3 2023 Earnings: Key financials and quarterly highlights
3 Struggling Stocks Investors Shouldn't Buy on the Dip
Is Biogen Stock a Buy Now?
Does Biogen's Latest $1.5 Billion-Dollar Move Make It a Buy?
Better Buy: Biogen vs. Eli Lilly
Could This $6.5 Billion Acquisition Help Turn Biogen's Business Around?
Better Alzheimer's Drug Stock: Eli Lilly vs. Biogen
Why Sage Therapeutics Stock Is Tumbling Today
BIIB Earnings: A snapshot of Biogen’s Q2 2023 financial results
Why Biogen Stock Got Sick Today
Biogen (BIIB) Q2 2023 Earnings Call Transcript
Better Big Biotech Buy: Vertex vs. Biogen
Should You Buy the Dip With Biogen Stock Right Now?
These 2 Numbers Should Scare Every Biogen Shareholder
Biogen Just Reached a Big Milestone. Why Isn't the Stock Rising?
Does This Signal Trouble for Biogen's New Alzheimer's Drug?
2 Market-Beating Stocks With Major Catalysts on the Way
These 2 Pharma Stocks Might Face Off Soon -- but They Could Both Win
3 Reasons to Buy Biogen Stock (and 1 to Sell)
Biogen Inc (BIIB) Q1 2023 Earnings Call Transcript
About · FAQs · StocksCafe © 2024 · Privacy · Terms